FR2542616B1 - Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel - Google Patents

Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel

Info

Publication number
FR2542616B1
FR2542616B1 FR8304378A FR8304378A FR2542616B1 FR 2542616 B1 FR2542616 B1 FR 2542616B1 FR 8304378 A FR8304378 A FR 8304378A FR 8304378 A FR8304378 A FR 8304378A FR 2542616 B1 FR2542616 B1 FR 2542616B1
Authority
FR
France
Prior art keywords
antibiotic
gel
composition
treatment
forming hydrocolloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8304378A
Other languages
English (en)
Other versions
FR2542616A1 (fr
Inventor
Pierre Piffeteau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Priority to FR8304378A priority Critical patent/FR2542616B1/fr
Priority to AT84301806T priority patent/ATE67662T1/de
Priority to DE8484301806T priority patent/DE3485100D1/de
Priority to EP84301806A priority patent/EP0125759B1/fr
Publication of FR2542616A1 publication Critical patent/FR2542616A1/fr
Application granted granted Critical
Publication of FR2542616B1 publication Critical patent/FR2542616B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
FR8304378A 1983-03-17 1983-03-17 Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel Expired FR2542616B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8304378A FR2542616B1 (fr) 1983-03-17 1983-03-17 Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
AT84301806T ATE67662T1 (de) 1983-03-17 1984-03-16 Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
DE8484301806T DE3485100D1 (de) 1983-03-17 1984-03-16 Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
EP84301806A EP0125759B1 (fr) 1983-03-17 1984-03-16 Composition topique à base d'antibiotiques pour le traitement des muqueuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8304378A FR2542616B1 (fr) 1983-03-17 1983-03-17 Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel

Publications (2)

Publication Number Publication Date
FR2542616A1 FR2542616A1 (fr) 1984-09-21
FR2542616B1 true FR2542616B1 (fr) 1987-07-31

Family

ID=9286960

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8304378A Expired FR2542616B1 (fr) 1983-03-17 1983-03-17 Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel

Country Status (4)

Country Link
EP (1) EP0125759B1 (fr)
AT (1) ATE67662T1 (fr)
DE (1) DE3485100D1 (fr)
FR (1) FR2542616B1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
FR2572932B1 (fr) * 1984-11-14 1987-01-23 Martin Henri Medicament insoluble administre localement dans l'oreille
JPS61229822A (ja) * 1985-03-29 1986-10-14 フアイザー・インコーポレーテツド チオコナゾールおよびその関連化合物からなる性的伝染病の予防剤
NZ222698A (en) * 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
CA2014244A1 (fr) * 1989-04-13 1990-10-13 Takeda Chemical Industries, Ltd. Composes d'anthracycline stabilises
FR2653021A1 (fr) * 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
FR2694194B1 (fr) * 1992-07-31 1994-11-04 Health Business Dev Gel hydratant, médicament et composition cosmétique le contenant, procédé de préparation dudit gel.
HU215443B (hu) * 1994-07-25 1999-04-28 Márton Milánkovits Többféle hatóanyagot tartalmazó gyógyszerkészítmények, főként hüvelykúp, baktericid, fungicid, protozoa- és vírusellenes kombinált hatással
ATE236616T1 (de) * 1995-09-29 2003-04-15 Lam Pharmaceutical Corp Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
JP4439119B2 (ja) * 1998-10-05 2010-03-24 株式会社ヤクルト本社 抗菌剤及びその製造法
EP1267826B1 (fr) * 1999-10-22 2007-01-03 Lif-Hlaup Ehf. Bio-Gels Pharmaceuticals Inc. Composition pharmaceutique pour le traitement de l'ulceration et/ou erosion epitheliale des muqueuses
DE60114620T2 (de) * 2000-06-30 2006-07-27 Polydex Pharmaceuticals Ltd. Verwendung von Cellulosesulfat und anderen sulfatierten Polysacchariden zur Vorbeugung und Behandlung von Papilloma-Virus-Infektionen
HU0104790D0 (en) * 2001-11-08 2002-01-28 Human Rt Pharmaceutical combinations for topical application
AU2012200105B2 (en) * 2004-10-20 2014-11-20 Care & Pharma Perspectives Sa Bioadhesive composition with programmed release
FR2876581B1 (fr) * 2004-10-20 2007-05-18 Interpharm Dev Composition bioadhesive a liberation programmee

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE959219C (de) * 1954-07-03 1957-02-28 Merz & Co Verfahren zur Herstellung von Schleimsalben
US4318746A (en) * 1980-01-08 1982-03-09 Ipco Corporation Highly stable gel, its use and manufacture
CA1184492A (fr) * 1981-01-14 1985-03-26 Masataka Morishita Produit caracterise par d'excellentes proprietes d'absorption

Also Published As

Publication number Publication date
FR2542616A1 (fr) 1984-09-21
EP0125759B1 (fr) 1991-09-25
DE3485100D1 (de) 1991-10-31
ATE67662T1 (de) 1991-10-15
EP0125759A2 (fr) 1984-11-21
EP0125759A3 (en) 1986-06-25

Similar Documents

Publication Publication Date Title
FR2542616B1 (fr) Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
ATE163863T1 (de) Gelwundverbandszusammensetzungen und verfahren zu deren gebrauch
BR9714935A (pt) Composição veterinária, intramamária isenta de agente antinfeccioso
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE3765146D1 (de) Vernetzte karboxylgruppen enthaltende kopolymere, verwendbar als verdickungsmittel in waessrigen systemen und deren herstellung.
FR2302750A1 (fr) Composition de gel de traitement de l'air
ES2024641B3 (es) Preservativo.
FR2332029A1 (fr) Gel de traitement de l'air
DK206688D0 (da) Topisk straalebeskyttende gel for mucosa
DE68912020T2 (de) N-2,3-Butadienyl-tri-aminoalkanderivate.
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
FI830523A0 (fi) Anti-inflammatoriska och/eller smaerta lindrande 2,3-diaryl-5-halotiofener
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
SE9403905D0 (sv) New formulations
OA07270A (fr) Dérivés N-(vinblastinoyl-23) d'acide aminés, leur préparation et leur application thérapeutique.
FR2557797B1 (fr) Composition therapeutique a base de terminalia chebula pour le traitement du psoriasis par voie orale.
BE885941A (fr) Adjuvant favorisant l'absorption de substances pharmacologiques par le rectum, et composition de base et composition pharmaceutique comprenant cet adjuvant
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
FR2401951A1 (fr) Gels de derives de galactomannanes
FR2713087B1 (fr) Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
RO82716B1 (ro) Unguent gel cu actiune cicatrizanta si antivaricoasa
IT8224440A0 (it) Nuovo derivato di 2,3-benzodiazina e relative composizioni farmaceutiche.
RO96917A2 (fr) Onguent hydrophyle anionique

Legal Events

Date Code Title Description
TP Transmission of property